Iris Lodewijk

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancer.

CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancer.

Journal: Scientific reports

Published: September 02, 2025

Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models.

Cell-of-origin and genetic drivers define advanced bladder cancer subtypes and potential therapeutic response in mouse models.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 26, 2025

Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer.

Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer.

Journal: Oncoimmunology

Published: December 19, 2024

CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.

CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.

Journal: Frontiers in immunology

Published: August 04, 2023

Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.

Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.

Journal: Cell death discovery

Published: June 28, 2023

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.

BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.

Journal: European urology

Published: February 21, 2022

Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.

Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.

Journal: Cancers

Published: December 26, 2021

Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer.

Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer.

Journal: Cancers

Published: November 30, 2021

Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy.

Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy.

Journal: NPJ precision oncology

Published: April 05, 2021

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.

Journal: Clinical epigenetics

Published: January 13, 2021

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.

Journal: The Journal of experimental medicine

Published: September 23, 2019

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.

Journal: Frontiers in genetics

Published: June 19, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026